Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by A. B. Sibley
Gene Expression Markers of Efficacy and Resistance to Cetuximab Treatment in Metastatic Colorectal Cancer: Results From CALGB 80203 (Alliance)
Clinical Cancer Research
Cancer Research
Oncology
Related publications
PTEN Loss of Expression Predicts Cetuximab Efficacy in Metastatic Colorectal Cancer Patients
British Journal of Cancer
Cancer Research
Oncology
Cetuximab in First Line Treatment of Metastatic Colorectal Cancer
Farmeconomia. Health economics and therapeutic pathways
Mechanism of Resistance to Cetuximab Therapy in Colorectal Cancer
mAbs
Allergy
Immunology
Current Status of Treatment of Metastatic Colorectal Cancer With Special Reference to Cetuximab and Elderly Patients
OncoTargets and Therapy
Oncology
Pharmacology
Safety and Efficacy of the Addition of Simvastatin to Cetuximab in Previously Treated KRAS Mutant Metastatic Colorectal Cancer Patients
Investigational New Drugs
Oncology
Pharmacology
Molecular Targeted Treatment of Metastatic Colorectal Cancer: The Cardiovascular Adverse Effects of Bevacizumab and Cetuximab
Medicine and Pharmacy Reports
Medicine
Systematic Review and Economic Evaluation of Bevacizumab and Cetuximab for the Treatment of Metastatic Colorectal Cancer
Health Technology Assessment
Medicine
Health Policy
Fluorouracil, Leucovorin, and Oxaliplatin With and Without Cetuximab in the First-Line Treatment of Metastatic Colorectal Cancer
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Evolving Role of Cetuximab in the Treatment of Colorectal Cancer
Cancer Management and Research
Oncology